| 1 |
Doust YV, Bindoff A, Holloway OG, Wilson R, King AE, Ziebell JM. Temporal changes in the microglial proteome of male and female mice after a diffuse brain injury using label-free quantitative proteomics. Glia 2023;71:880-903. [PMID: 36468604 DOI: 10.1002/glia.24313] [Reference Citation Analysis]
|
| 2 |
Kovács-Öller T, Zempléni R, Balogh B, Szarka G, Fazekas B, Tengölics ÁJ, Amrein K, Czeiter E, Hernádi I, Büki A, Völgyi B. Traumatic Brain Injury Induces Microglial and Caspase3 Activation in the Retina. Int J Mol Sci 2023;24. [PMID: 36901880 DOI: 10.3390/ijms24054451] [Reference Citation Analysis]
|
| 3 |
Rauchman SH, Zubair A, Jacob B, Rauchman D, Pinkhasov A, Placantonakis DG, Reiss AB. Traumatic brain injury: Mechanisms, manifestations, and visual sequelae. Front Neurosci 2023;17:1090672. [PMID: 36908792 DOI: 10.3389/fnins.2023.1090672] [Reference Citation Analysis]
|
| 4 |
Honig MG, Del Mar NA, Moore BM, Reiner A. Raloxifene Mitigates Emotional Deficits after Mild Traumatic Brain Injury in Mice. Neurotrauma Reports 2022;3:534-544. [DOI: 10.1089/neur.2022.0052] [Reference Citation Analysis]
|
| 5 |
Olakowska E, Rodak P, Pacwa A, Machowicz J, Machna B, Lewin-kowalik J, Smedowski A. Surgical Menopause Impairs Retinal Conductivity and Worsens Prognosis in an Acute Model of Rat Optic Neuropathy. Cells 2022;11:3062. [DOI: 10.3390/cells11193062] [Reference Citation Analysis]
|
| 6 |
Doust YV, Bindoff A, Holloway OG, Wilson R, King AE, Ziebell JM. Temporal changes in the microglial proteome of male and female mice after a diffuse brain injury using label-free quantitative proteomics.. [DOI: 10.1101/2022.05.01.490239] [Reference Citation Analysis]
|
| 7 |
Neely C, Barkey R, Hernandez C, Flinn J. Prophylactic zinc supplementation modulates hippocampal ionic zinc and partially remediates neurological recovery following repetitive mild head injury in mice. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113918] [Reference Citation Analysis]
|
| 8 |
Honig MG, Del Mar NA, Henderson DL, O'Neal D, Yammanur M, Cox R, Li C, Perry AM, Moore BM, Reiner A. Raloxifene, a cannabinoid type-2 receptor inverse agonist, mitigates visual deficits and pathology and modulates microglia after ocular blast. Exp Eye Res 2022;:108966. [PMID: 35143834 DOI: 10.1016/j.exer.2022.108966] [Reference Citation Analysis]
|
